fract

Zynerba Pharm INC Pullback

NASDAQ:ZYNE   None
When it comes to pullbacks Zynerba is doing well there, especially it becomes more considerable when we see that price is getting close and close to all time lows.
Buying now is ok but a little riskier than buying when price touches or enters down inside green area and touches closest fib line.
A movement from current price to $4 is 40% increase and we know the nature of such pullback growth is very rapid according to the history of fluctuations.
Another place to buy is at upward breakout from giant triangle but it is in a distant future to even thing about it now.
This company is a risky for long-term investment but if the fundamentals and business overall will do well then it can make x's. For example if FDA fully approves their Zgel or recognizes clinical trials any of their other products whatever they're making right now, price can take off vertically.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.